Common Shares Outstanding: The number of class A shares currently held by investors.
Takeda Pharmaceutical Co. (TAK) had Common Shares Outstanding of 3.12B for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$7.64B |
|
$857.28M |
|
$2.65B |
|
$4.98B |
|
$6.36B |
|
$1.27B |
|
$-234.16M |
|
$1.04B |
|
$1.04B |
|
$857.53M |
|
$857.53M |
|
$857.53M |
|
$857.53M |
|
$1.27B |
|
$2.53B |
|
3.13B |
|
3.13B |
|
$0.27 |
|
$0.27 |
|
| Balance Sheet Financials | |
$17.34B |
|
$13.50B |
|
$79.29B |
|
$96.63B |
|
$14.97B |
|
$28.53B |
|
$34.28B |
|
$49.25B |
|
$47.38B |
|
$-12.78B |
|
$47.38B |
|
|
Common Shares Outstanding |
3.12B |
| Cash Flow Statement Financials | |
$1.49B |
|
$-229.03M |
|
$-1.48B |
|
$2.66B |
|
$2.42B |
|
$-242.22M |
|
$114.06M |
|
$-1.00B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.16 |
|
-- |
|
-- |
|
0.38 |
|
0.66 |
|
65.24% |
|
16.68% |
|
16.68% |
|
-- |
|
13.61% |
|
11.23% |
|
$1.20B |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
0.31 |
|
1.63 |
|
55.26 |
|
1.81% |
|
-6.71% |
|
0.89% |
|
1.13% |
|
$15.17 |
|
$0.38 |
|
$0.47 |
|